Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Non-Current Assets (2024 - 2025)

Historic Non-Current Assets for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $22.5 million.

  • Pyxis Oncology's Non-Current Assets fell 5148.68% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.5 million, marking a year-over-year change of. This contributed to the annual value of $24.7 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Pyxis Oncology's Non-Current Assets stood at $22.5 million, which was down 5148.68% from $23.3 million recorded in Q2 2025.
  • Pyxis Oncology's Non-Current Assets' 5-year high stood at $47.8 million during Q1 2024, with a 5-year trough of $22.5 million in Q3 2025.